Co-Diagnostics has signed an exclusive distribution agreement with its long-term partner in Mexico to deploy its Co-Dx PCR Pro platform and related molecular diagnostic products. This deal extends their partnership by five years and aims to expand Co-Diagnostics' presence in Latin America, particularly Mexico, the region's second largest market by population. The company plans to offer a broader range of infectious disease tests beyond COVID-19, including tuberculosis and Ebola assays, pending regulatory approvals. This agreement builds on past success, where their COVID-19 PCR tests dominated over half of Mexico's testing market through 2021.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Frasers Group PLC has withheld financial guidance for the upcoming year due to uncertainty around its takeover bids for Hugo Boss and Accent Group. The retailer's full-year adjusted profit before tax fell 4% to £538 million, impacted by asset impairm...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
